Innovative Neuroscience To Improve Treatment Of Sleep Disturbances For Prevention Of Depression And Anxiety
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Insomnia patients have disturbed sleep and symptoms similar to people with depression and anxiety. Treatments are far from optimal and have not progressed since the beginning of the century. My pioneering work identified insomnia patients at risk of depression and anxiety and revealed a potential way of targeting disturbed sleep to resolve emotional distress. Now, my mission is to understand why they are at risk and develop innovative treatments that reduce their risk for depression and anxiety.
The Kids Aren’t Alright: Preventing Depression In Adolescents
Funder
National Health and Medical Research Council
Funding Amount
$600,715.00
Summary
Depression frequently emerges for the first-time during adolescence. This project examines ways to prevent depression in young people by: (i) partnering with schools to deliver broad universal programs to students through the education system, and (ii) treating sleep disturbance, a powerful but non-stigmatised risk factor for onset of depression. Findings from this research will inform innovative ways to address the depression crisis through the optimisation of prevention approaches.
Targeting The Immune Cells Of The Brain To Develop Novel Treatments For Neurodevelopmental And Mental Health Problems In Children
Funder
National Health and Medical Research Council
Funding Amount
$1,800,000.00
Summary
Neurodevelopmental and mental health problems are common in children and cause major impairment and cost to society. This research will define how the maternal immune system while pregnant can affect the baby brain. Using patient studies and laboratory research, this research will result in novel ways to reduce the prevalence and severity of developmental and mental health problems in children and adults, by targeting the immune cells resident in the brain.
Melanoma Genetics: Clinical Translation Of The Germline-somatic Continuum
Funder
National Health and Medical Research Council
Funding Amount
$2,231,372.00
Summary
While new targeted and immune therapies can improve prognosis from metastatic melanoma, long-term survival for most patients remains elusive due to drug resistance or failure of the immune system to kill the tumour. There thus remains a significant need to improve early detection, monitoring of relapse, and treatment strategies, to increase survival and provide cures. My research vision addresses these three pillars of cancer research using innovative and cutting edge genetic approaches.
Minimising Uptake Of E-cigarettes And Encouraging Cessation Among Australian Adolescents And Adults
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Efforts are needed to address the growing use of e-cigarettes among Australians to prevent potential increases in smoking rates and minimise harm. My research aims to: 1. Develop and test a model examining predictors of e-cigarette use and susceptibility to use among adolescents and adults. 2. Develop, implement, and evaluate messages that effectively minimise uptake and encourage cessation of e-cigarette use. 3. Develop resources for stakeholders that provide guidance on managing use.
Translation Of Genomic Findings To Improve Outcomes In Patients With Myeloid Blood Cancers
Funder
National Health and Medical Research Council
Funding Amount
$1,913,403.00
Summary
Changes within the DNA of blood cancer cells are responsible for causing cancer, but also control the progression through various stages of blood cancers and regulate the response of patients to treatment. It is fundamentally important to not only understand these genetic changes at the molecular level, but also to use these findings to rationally design clinical treatments that target these genetic changes to improve outcomes for patients with blood cancers.
Developing New Treatment Approaches For Severe And Treatment Resistant Depression
Funder
National Health and Medical Research Council
Funding Amount
$2,060,520.00
Summary
Depression is a common, disabling problem. One third of depressed patients do not respond to treatment with standard medications and psychological therapy. This research program will focus on developing new treatment approaches for these people: optimising electroconvulsive therapy, a highly effective treatment, developing new non invasive brain stimulation treatments, generating new knowledge on how best to use ketamine treatment.
Developing Novel Therapeutic Approaches To Treat Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$2,173,545.00
Summary
Progression of chronic kidney disease (CKD) to endstage is characterised by inflammation and fibrosis. No current treatment effectively halts CKD progression. We are using protective immune cells to treat CKD and have invented a genetically-engineered immune cell which uses damaging inflammatory signals to switch them into protective cells which reverse inflammation and fibrosis where they occur, to prevent progression of CKD and other diseases, such as those of heart, lung and liver.
Teaching An Old Brain New Tricks: Optimising Cognitive Training Through Neuroplasticity
Funder
National Health and Medical Research Council
Funding Amount
$1,562,250.00
Summary
People with early dementia have the most to gain from brain training programs aimed at delaying deterioration. Yet, its power is under-realised, with improvements not generalising to everyday living. This research program will harness the power of neuroplasticity to optimise brain training so that the effects transfer to everyday life. The knowledge gained will transform the way that we design and deliver brain training programs and revolutionise our understanding of why and how people respond.
Addressing Evidence Gaps And Developing A Novel Treatment To Reduce The Burden Of Post-traumatic Knee Osteoarthritis
Funder
National Health and Medical Research Council
Funding Amount
$645,205.00
Summary
Arthritis caused by knee injury has a devastating personal and economic impact. Research is needed to develop strategies to prevent arthritis and improve outcomes for people living with arthritis. This research will improve treatment of knee injury to reduce arthritis risk, understand why some people are more likely to get knee arthritis, and develop a new treatment to improve outcomes for people living with knee arthritis. A clinical trial will determine if this treatment achieves this aim.